2
SOLUTIONS FOR IN/OUT-LICENSING ACTIVITIES In and out-licensing activities are excellent opportunities for companies that want to quickly expand their portfolio or obtain an immediate return on investment, respectively. However, it is crucial to gain a deep knowledge on the market and the clinical profile of the drugs in order to de-risk scientific decisions during the due-diligence process. What can Anaxomics do for you? Anaxomics provides a rationale for in/out-licensing decisions based on their expected clinical performance and a comprehensive cross-examination of the competitive landscape. To do so, we offer a novel approach to due diligence that combines cutting-edge Systems Biology with long-term expertise in drug development. Our innovative TPMS technology provides a complete understanding of the therapeutic performance and the mechanism of action of a drug, allowing us to offer the following services: Why is Systems Biology useful for you? Being fully conscious of the risks that the drug development process entails, we offer innovative solutions aimed at reducing costs and maximizing profit starting from early stages: Predicting rate of success in terms of safety or efficacy Helping you to cancel bad investments as early as possible Providing the best strategies to exploit your pipeline Highlighting the values of the molecules and identifying their strengths vs. its competitors 1. Clinical Benchmarking: Comparison of new products with the standard of care 2. Safety Assessment: Evaluation of main safety risks of compounds or technologies 3. Efficacy Assessment: Estimation of agents’ efficacy in terms of potential indications 4. Integrated Product Assessment: Estimation of the clinical profile of therapeutic agents 5. Market analysis: Exploration of the competitors landscape, IP opportunities and strategy assessment for the products in the pipeline Safety profile of a drug Comparison with marketed drugs Efficacy assessment of new drugs

SOLUTIONS FOR IN/OUT-LICENSING ACTIVITIES · 2017-01-31 · SOLUTIONS FOR IN/OUT-LICENSING ACTIVITIES In and out-licensing activities are excellent opportunities for companies that

  • Upload
    others

  • View
    2

  • Download
    0

Embed Size (px)

Citation preview

SOLUTIONS FOR IN/OUT-LICENSING ACTIVITIES

In and out-licensing activities are excellent opportunities for companies that want to quickly expand their portfolio or obtain an immediate return on investment, respectively. However, it is crucial to gain a deep knowledge on the market and the clinical profile of the drugs in order to de-risk scientific decisions during the due-diligence process.

What can Anaxomics do for you?Anaxomics provides a rationale for in/out-licensing decisions based on their expected clinical performance and a comprehensive cross-examination of the competitive landscape. To do so, we offer a novel approach to due diligence that combines cutting-edge Systems Biology with long-term expertise in drug development.

Our innovative TPMS technology provides a complete understanding of the therapeutic performance and the mechanism of action of a drug, allowing us to offer the following services:

Why is Systems Biology useful for you?Being fully conscious of the risks that the drug development process entails, we offer innovative solutions aimed at reducing costs and maximizing profit starting from early stages:

Predicting rate of success in terms of safety or efficacy

Helping you to cancel bad investments as early as possible

Providing the best strategies to exploit your pipeline

Highlighting the values of the molecules and identifying their strengths vs. its competitors

1. Clinical Benchmarking: Comparison of new products with the standard of care

2. Safety Assessment: Evaluation of main safety risks of compounds or technologies

3. Efficacy Assessment: Estimation of agents’ efficacy in terms of potential indications

4. Integrated Product Assessment: Estimation of the clinical profile of therapeutic agents

5. Market analysis: Exploration of the competitors landscape, IP opportunities and strategy assessment for the products in the pipeline

Safety profile of a drug Comparison with marketed drugs Efficacy assessment of new drugs

What do you get with this service?Anaxomics provides its clients with comprehensive reports that give a thorough examination to the subject under study, taking into account the particular needs of the project. The versatility of Anaxomics’ TPMS allows us to provide a wide array of personalized services specifically directed to companies seeking in- or out-licensing opportunities.

Moreover, because we believe that cooperation is the key to success, we work in tight interaction with our clients. We offer assistance from highly skilled professionals with long experience in the fields of clinical research and drug development.

To whom is this service addressed? We at Anaxomics are glad to offer our services to interested clients and, more specifically, to:

Why Anaxomics? The Anaxomics team is composed of highly-qualified experts in clinical research, computational science and systems biology. Anaxomics is a client-focused company, with a strong emphasis on quality and innovative approaches to solve bottlenecks in drug discovery and clinical development.

Anaxomics Biotechc/Balmes, 89, 4º 2ª 08008, BarcelonaSpain

Our experience is our best assetWe have offered services to a wide array of leading biotech and pharmaceutical companies. Additionally, we regularly

collaborate with prestigious international research institutions in public-private partnerships. Anaxomics currently

participates in eight research consortiums under the EU 7th Framework Program, and has also been involved in FIS, CDTI,

CANADEKA and other publicly funded research programmes.

Anaxomics has also been finalist for the 2011 Red Herring Top 100 Innovative

European Company Award and 4th place worldwide in IMPROVER challenge 2012

Contact us: We are pleased to answer your questions and queries.

Comprehensive reports Tight collaboration with clients Personalized services

you

Pharmaceutical companies

Biotechnology companies

Venture capitals and investors

Integrated product

assessment

Efficacy assessment

Safety assessment

Market analysis

Clinical benchmark-

ing

If you want different results, then you have to explore different solutions

Albert Einstein

[email protected]

+34 93 451 67 17

www.anaxomics.com